Atomistry » Zinc » PDB 4i7d-4ih7 » 4i9z
Atomistry »
  Zinc »
    PDB 4i7d-4ih7 »
      4i9z »

Zinc in PDB 4i9z: Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors

Enzymatic activity of Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors

All present enzymatic activity of Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors:
3.1.4.35;

Protein crystallography data

The structure of Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors, PDB code: 4i9z was solved by J.Ren, T.Chen, Y.Xu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 46.30 / 2.08
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 74.850, 74.850, 132.280, 90.00, 90.00, 120.00
R / Rfree (%) 20.1 / 23.7

Other elements in 4i9z:

The structure of Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors also contains other interesting chemical elements:

Bromine (Br) 1 atom
Magnesium (Mg) 1 atom

Zinc Binding Sites:

The binding sites of Zinc atom in the Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors (pdb code 4i9z). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors, PDB code: 4i9z:

Zinc binding site 1 out of 1 in 4i9z

Go back to Zinc Binding Sites List in 4i9z
Zinc binding site 1 out of 1 in the Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure of the PDE5A1 Catalytic Domain in Complex with Novel Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn902

b:31.2
occ:1.00
 OD1 A:ASP654 2.1 18.8 1.0
NE2 A:HIS617 2.2 17.2 1.0
NE2 A:HIS653 2.2 16.2 1.0
O A:HOH1004 2.2 21.2 1.0
OD2 A:ASP764 2.3 19.4 1.0
O A:HOH1138 2.4 19.9 1.0
CD2 A:HIS617 3.1 17.1 1.0
CD2 A:HIS653 3.1 18.0 1.0
CG A:ASP654 3.1 20.4 1.0
CG A:ASP764 3.2 24.5 1.0
CE1 A:HIS617 3.2 18.9 1.0
CE1 A:HIS653 3.3 17.4 1.0
OD1 A:ASP764 3.5 26.8 1.0
OD2 A:ASP654 3.7 19.6 1.0
MG A:MG903 3.9 26.2 1.0
O A:HOH1055 4.0 27.7 1.0
O A:HOH1137 4.0 19.9 1.0
CD2 A:HIS613 4.1 22.4 1.0
NE2 A:HIS613 4.3 22.8 1.0
CG A:HIS617 4.3 17.4 1.0
CG A:HIS653 4.3 20.4 1.0
ND1 A:HIS617 4.3 17.7 1.0
ND1 A:HIS653 4.3 15.1 1.0
CB A:ASP654 4.3 19.3 1.0
CB A:ASP764 4.6 19.4 1.0
O A:ASP764 4.7 17.5 1.0
O A:HOH1002 4.8 22.8 1.0
OG1 A:THR621 4.9 15.0 1.0
CA A:ASP764 4.9 17.1 1.0

Reference:

X.Gong, G.Wang, J.Ren, Z.Liu, Z.Wang, T.Chen, X.Yang, X.Jiang, J.Shen, H.Jiang, H.A.Aisa, Y.Xu, J.Li. Exploration of the 5-Bromopyrimidin-4(3H)-Ones As Potent Inhibitors of PDE5. Bioorg.Med.Chem.Lett. V. 23 4944 2013.
ISSN: ISSN 0960-894X
PubMed: 23867165
DOI: 10.1016/J.BMCL.2013.06.062
Page generated: Sun Oct 27 00:35:07 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy